<DOC>
	<DOCNO>NCT02499510</DOCNO>
	<brief_summary>The GoldenFlow ( Lifetech Scientific , Shenzhen , China ) novel woven-nitinol stent design superior radial strength , flexibility durability compare standard nitinol stent femoropopliteal lesion . This first-in-man study evaluate safety efficacy GoldenFlow woven-nitinol stent intraluminal treatment peripheral vascular disease femoropopliteal artery .</brief_summary>
	<brief_title>First-in-man Study Titanium-Nitride Coated Woven-nitinol Peripheral Arterial Stent</brief_title>
	<detailed_description>Endovascular treatment femoropopliteal segment challenge area due restenosis stent fracture endovascular treatment . The titanium-nitride coated woven-nitinol peripheral arterial stent system ( GoldenFlow , Lifetech Science , Shenzhen , China ) design superior radial strength , flexibility durability withstand compression , torsion , bending , lengthen shorten find femoropopliteal disease . Compared another commercially available woven-nitinol stent , GoldenFlow stent potential advantage repositionable less likely lengthen deployment . This first-in-man study evaluate safety efficacy GoldenFlow woven-nitinol stent intraluminal treatment peripheral vascular disease de-novo femoropopliteal lesion .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Age ≥18 year 2 . Symptomatic leg ischemia ( Rutherford class 2 4 ) 3 . Ankle Brachial Index &lt; 0.9 4 . De novo femoropopliteal stenosis ( ≥70 % ) occlusion 5 . Reference diameter 4 7mm 6 . Lesion length 4 15cm 7 . At least one patent ( &lt; 50 % stenosis ) infrapopliteal runoff vessel 8 . The lesion ( ) successfully cross guidewire dilate 9 . Patients bilateral femoropopliteal disease eligible enrollment study Staged contralateral limb procedure perform &gt; 30 day index procedure 10 . Able provide write informed consent willing comply specify followup evaluation schedule 1 . Tissue loss gangrene ( Rutherford class 5 6 ) 2 . Previous bypass surgery stenting target vessel 3 . Untreated aortoiliac common femoral artery inflow disease &gt; 50 % 4 . Intervention ipsilateral lesion index procedure stag intervention within 30 day index procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>femoropopliteal disease</keyword>
	<keyword>restenosis</keyword>
</DOC>